Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions.

[1]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[2]  M. Rubin,et al.  Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy. , 2002, Urology.

[3]  S. Freedland,et al.  Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. , 2002, The Journal of urology.

[4]  M. Rubin,et al.  Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. , 2000, The American journal of surgical pathology.

[5]  M. Rubin,et al.  Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage. , 1999, Urology.

[6]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[7]  T. Stamey,et al.  Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.

[8]  K. Shinohara,et al.  Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. , 1998, Urology.

[9]  M. Kattan,et al.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. , 1998, Journal of the National Cancer Institute.

[10]  A. D'Amico,et al.  Outcome based staging for clinically localized adenocarcinoma of the prostate. , 1997, The Journal of urology.

[11]  H. Lai,et al.  Survival after radical prostatectomy. , 1997, JAMA.

[12]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[13]  A. Partin,et al.  Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.

[14]  A. Renshaw,et al.  Calculated prostate cancer volume: the optimal predictor of actual cancer volume and pathologic stage. , 1997, Urology.

[15]  M W Kattan,et al.  Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma , 1997, Cancer.

[16]  P. Schellhammer,et al.  Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.

[17]  M. Kattan,et al.  Prognostic significance of positive surgical margins in radical prostatectomy specimens. , 1995, The Journal of urology.

[18]  D. Fryback,et al.  Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.

[19]  J. Oesterling,et al.  The clinical usefulness of prostate specific antigen: update 1994. , 1994, The Journal of urology.

[20]  P. Scardino,et al.  The new american joint committee on cancer and international union against cancer tnm classification of prostate cancer , 1994, Cancer.

[21]  A. V. von Eschenbach,et al.  The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy , 1994, Cancer.

[22]  P. Walsh,et al.  Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. , 1993, The Journal of urology.

[23]  Galina Pizov,et al.  Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.

[24]  R. B. Smith,et al.  Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. , 1992, The Journal of urology.

[25]  J. Oesterling,et al.  Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. , 1987, The Journal of urology.

[26]  Gleason Df.  Classification of prostatic carcinomas. , 1966 .